First, we started with a candidate approach, focusing on the genes that are known to be associated with melanoma growth and in particular response to immunotherapy, including known melanoma-promoting genes PD-1 (PDCD1)35, PD-L1 (CD274)11,36, and CD4737–39. This evidence concerns the gene CD274 and melanoma.